View Inc
NASDAQ:VIEW
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
View Inc
Cash Equivalents
View Inc
Cash Equivalents Peer Comparison
Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
View Inc
NASDAQ:VIEW
|
Cash Equivalents
$66.6m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Owens Corning
NYSE:OC
|
Cash Equivalents
$1.3B
|
CAGR 3-Years
28%
|
CAGR 5-Years
73%
|
CAGR 10-Years
34%
|
|
Carlisle Companies Inc
NYSE:CSL
|
Cash Equivalents
$552.6m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-3%
|
|
Carrier Global Corp
NYSE:CARR
|
Cash Equivalents
$10B
|
CAGR 3-Years
48%
|
CAGR 5-Years
55%
|
CAGR 10-Years
N/A
|
|
Lennox International Inc
NYSE:LII
|
Cash Equivalents
$45.7m
|
CAGR 3-Years
9%
|
CAGR 5-Years
8%
|
CAGR 10-Years
2%
|
|
Builders FirstSource Inc
NYSE:BLDR
|
Cash Equivalents
$697.5m
|
CAGR 3-Years
232%
|
CAGR 5-Years
125%
|
CAGR 10-Years
27%
|
See Also
What is View Inc's Cash Equivalents?
Cash Equivalents
66.6m
USD
Based on the financial report for Dec 31, 2022, View Inc's Cash Equivalents amounts to 66.6m USD.
What is View Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 3Y
-14%
Over the last year, the Cash Equivalents growth was -73%. The average annual Cash Equivalents growth rates for View Inc have been -14% over the past three years .